Abstract
Oral delivery of vaccines is able to induce systemic as well as mucosal immune responses but is largely inefficient due to intestinal degradation and impermeable barrier property of GIT of administered antigen. Efforts are being made to develop a safe and effective oral vaccination by offering resistant against acidic and enzymatic degradation before reaching to the target site. Several strategies are developed to target antigen to the gut associated lymphoid tissue (GALT) present in the intestine where antigen-specific immune responses are initiated. This review discusses various technologies and targets for antigen delivery to induce protective immunization by oral vaccine.
Keywords: M-cell ligand, mucosal immunity, nanocarriers, oral vaccine.
Current Drug Therapy
Title:Newer Technologies in Oral Vaccine Delivery
Volume: 9 Issue: 3
Author(s): Jayamanti Pandit, Yasmin Sultana and Mohd. Abul Kalam
Affiliation:
Keywords: M-cell ligand, mucosal immunity, nanocarriers, oral vaccine.
Abstract: Oral delivery of vaccines is able to induce systemic as well as mucosal immune responses but is largely inefficient due to intestinal degradation and impermeable barrier property of GIT of administered antigen. Efforts are being made to develop a safe and effective oral vaccination by offering resistant against acidic and enzymatic degradation before reaching to the target site. Several strategies are developed to target antigen to the gut associated lymphoid tissue (GALT) present in the intestine where antigen-specific immune responses are initiated. This review discusses various technologies and targets for antigen delivery to induce protective immunization by oral vaccine.
Export Options
About this article
Cite this article as:
Pandit Jayamanti, Sultana Yasmin and Kalam Abul Mohd., Newer Technologies in Oral Vaccine Delivery, Current Drug Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574885509666141202232803
DOI https://dx.doi.org/10.2174/1574885509666141202232803 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Microglia and its Genetics in Alzheimer's Disease
Current Alzheimer Research Role of Angiogenesis Inhibitors in Colorectal Cancer: Sensitive and Insensitive Tumors
Current Cancer Drug Targets Immunotherapy in a Natural Model of Aβ Pathogenesis: The Aging Beagle
CNS & Neurological Disorders - Drug Targets Cytokine and Nitric Oxide Production Following Severe Envenomation
Current Drug Targets - Inflammation & Allergy Plant Proteinases and Inhibitors: An Overview of Biological Function and Pharmacological Activity
Current Protein & Peptide Science Properdin and Complement Activation: A Fresh Perspective
Current Drug Targets Natural Killer Cells: Prospects in Cancer Immunotherapy
Current Immunology Reviews (Discontinued) The Assessment of Anxiety and Depression and its Associated Factors in SLE
Current Rheumatology Reviews Recent Patents on Development of Nucleic Acid-based Antiviral Drugs against Seasonal and Pandemic Influenza Virus Infections
Recent Patents on Anti-Infective Drug Discovery Effects of Brain IKKβ Gene Silencing by Small Interfering RNA on P-Glycoprotein Expression and Brain Damage in the Rat Kainic Acid-Induced Seizure Model
CNS & Neurological Disorders - Drug Targets Editorial [Hot topic: Hepatocyte Growth Factor and cMET, New Development in Cancer Therapies (Guest Editors: T.A. Martin and W.G. Jiang)]
Anti-Cancer Agents in Medicinal Chemistry Minocycline as Add-On Treatment Decreases the Negative Symptoms of Schizophrenia; A Randomized Placebo-Controlled Clinical Trial
Recent Patents on Inflammation & Allergy Drug Discovery Prevalence of Analgesic Use and Pain in People with and without Dementia or Cognitive Impairment in Aged Care Facilities: A Systematic Review and Meta-Analysis
Current Clinical Pharmacology Snake Venom Phospholipase A2 Inhibitors: Medicinal Chemistry and Therapeutic Potential
Current Topics in Medicinal Chemistry Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents
Medicinal Chemistry Molecular and Cellular Mechanism of Cutaneous Injuries Due to Exposure to Sulfur Mustard
Letters in Drug Design & Discovery Cerebral Hypoperfusion in Hereditary Coproporphyria (HCP): A Single Photon Emission Computed Tomography (SPECT) Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Problems with Non-Specific COX Inhibitors
Current Pharmaceutical Design Algae, A Possible Source for New Drugs in the Treatment of HIV and Other Viral Diseases
Current Medicinal Chemistry - Anti-Infective Agents